Andere talen Sysmex Corporation

Aandelen

6869

JP3351100007

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 05-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.516 ^JPY	-0,45%		-2,88%	-3,93%

30/05	SYSMEX CORPORATION : Jefferies & Co. zet aandeel op kooplijst	ZM
13/02	Sysmex gaat 3-voor-1 aandelensplitsing uitvoeren; aandelen stijgen 4%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sysmex : Script file( PDF format / 2.6MB )	24/06
Sysmex : Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2024	09/05
Sysmex : Notice Regarding the Booking of a Loss on Valuation of Shares of Subsidiaries and Associates and a Provision for Loss on Guarantees (Non-Consolidated Financial Statements)	09/05
Sysmex : Announcement of Executive Change	09/05
Sysmex : Medicaroid Receives MHLW Approval for the Use of the hinotori™ Surgical Robot System in Thoracic Surgery (Medicaroid)	17/04
Sysmex : Announcement of Organizational and Personnel Changes	07/03
Sysmex to Carry Out 3-for-1 Stock Split; Shares Jump 4%	13/02
Sysmex Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	09/02
Sysmex Corporation Reaffirm Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
Cellavision, Sysmex Expand Hematology Partnership Deal	06/02
CellaVision and Sysmex Sign Strategic Alliance Agreement	06/02
CellaVision and Sysmex Corporation Sign Strategic Alliance Agreement	06/02
Germany’s USU Software Signs Knowledge Management Deal with Japan’s Sysmex	16/01
Sysmex : Expands Sales of Its Reagents for Blood-based Amyloid β Testing to Europe	25/12
Sysmex Corporation acquired additional unknown stake in Megakaryon Corporation.	21/12
Fujirebio and Sysmex sign agreement for the supply of reagent raw materials in the field of Immunoassay	15/12
Fujirebio Holdings, Inc. and Sysmex Corporation Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay	14/12
Sysmex : to Reinforce IVD Instrument Production to Support Total Solutions in Clinical Testing- Expansion of Subsidiary's Manufacturing Factory Ensures Stable Global Supply and Enhanced Laboratory Productivity	05/12
VCCT Inc announced that it has received ¥600 million in funding from YASKAWA Electric Corporation, Dai-Dan Co., Ltd., Sysmex Corporation	15/11
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary	03/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sysmex Corporation

Aandelen

6869

JP3351100007

Andere talen

Filters